Perpetual Ltd Boosts Holdings in Infosys Limited (NYSE:INFY)

Perpetual Ltd boosted its stake in shares of Infosys Limited (NYSE:INFY) by 20.3% during the 4th quarter, according to its most recent filing with the SEC. The firm owned 681,729 shares of the technology company’s stock after purchasing an additional 115,068 shares during the period. Perpetual Ltd’s holdings in Infosys were worth $14,944,000 at the end of the most recent quarter.

Other institutional investors have also modified their holdings of the company. Dimensional Fund Advisors LP raised its position in Infosys by 13.4% during the second quarter. Dimensional Fund Advisors LP now owns 6,040,195 shares of the technology company’s stock valued at $112,481,000 after acquiring an additional 715,812 shares in the last quarter. Mercer Global Advisors Inc. ADV grew its stake in shares of Infosys by 2.9% during the 2nd quarter. Mercer Global Advisors Inc. ADV now owns 17,632 shares of the technology company’s stock worth $328,000 after purchasing an additional 505 shares during the period. Vanguard Personalized Indexing Management LLC increased its holdings in shares of Infosys by 24.4% during the 2nd quarter. Vanguard Personalized Indexing Management LLC now owns 28,718 shares of the technology company’s stock valued at $535,000 after purchasing an additional 5,642 shares in the last quarter. Sei Investments Co. lifted its stake in shares of Infosys by 2.2% in the 2nd quarter. Sei Investments Co. now owns 1,038,666 shares of the technology company’s stock valued at $19,340,000 after purchasing an additional 21,961 shares during the period. Finally, Profund Advisors LLC boosted its holdings in Infosys by 8.6% during the second quarter. Profund Advisors LLC now owns 96,829 shares of the technology company’s stock worth $1,803,000 after buying an additional 7,640 shares in the last quarter. Hedge funds and other institutional investors own 16.20% of the company’s stock.

Infosys Stock Performance

Shares of INFY stock opened at $21.16 on Tuesday. Infosys Limited has a fifty-two week low of $16.04 and a fifty-two week high of $23.63. The firm has a market capitalization of $87.65 billion, a P/E ratio of 26.79, a PEG ratio of 3.45 and a beta of 1.00. The stock’s fifty day moving average is $22.53 and its two-hundred day moving average is $22.21.

Infosys (NYSE:INFY) last posted its quarterly earnings results on Thursday, January 16th. The technology company reported $0.19 earnings per share for the quarter, hitting analysts’ consensus estimates of $0.19. Infosys had a net margin of 17.28% and a return on equity of 31.60%. During the same quarter last year, the firm earned $0.18 EPS. On average, equities analysts forecast that Infosys Limited will post 0.74 earnings per share for the current year.

Wall Street Analysts Forecast Growth

A number of brokerages have weighed in on INFY. Hsbc Global Res upgraded shares of Infosys from a “hold” rating to a “strong-buy” rating in a research report on Monday, December 9th. BMO Capital Markets upped their price target on Infosys from $23.00 to $25.00 and gave the stock a “market perform” rating in a report on Friday, October 18th. Investec lowered Infosys from a “hold” rating to a “sell” rating in a report on Thursday, October 3rd. Guggenheim reaffirmed a “neutral” rating on shares of Infosys in a research note on Friday. Finally, StockNews.com cut shares of Infosys from a “buy” rating to a “hold” rating in a research note on Friday, January 3rd. Two research analysts have rated the stock with a sell rating, four have issued a hold rating, four have given a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat.com, the company has a consensus rating of “Hold” and a consensus target price of $20.22.

Infosys Company Profile

Infosys Ltd. is a digital services and consulting company, which engages in the provision of end-to-end business solutions. It operates through the following segments: Financial Services, Retail, Communication, Energy, Utilities, Resources, and Services, Manufacturing, Hi-Tech, Life Sciences, and All Other.